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Background: The Institute of Medicine (IOM) has endorsed six dimensions of patient-centredness as crucial to providing
quality healthcare. These dimensions outline that care must be: 1) respectful to patients’ values, preferences, and
expressed needs; 2) coordinated and integrated; 3) provide information, communication, and education; 4) ensure
physical comfort; 5) provide emotional support—relieving fear and anxiety; and 6) involve family and friends.
However, whether patient-reported outcome measures (PROMs) comprehensively cover these dimensions remains
unexplored. This systematic review examined whether PROMs designed to assess the quality of patient-centred cancer
care addressed all six IOM dimensions of patient-centred care and the psychometric properties of these measures.
Methods: Medline, PsycINFO, Current Contents, Embase, CINAHL and Scopus were searched to retrieve published
studies describing the development and psychometric properties of PROMs assessing the quality of patient-centred
cancer care. Two authors determined if eligible PROMs included the six IOM dimensions of patient-centred care and
evaluated the adequacy of psychometric properties based on recommended criteria for internal consistency, test-retest
reliability, face/content validity, construct validity and cross-cultural adaptation.
Results: Across all 21 PROMs, the most commonly included IOM dimension of patient-centred care was “information,
communication and education” (19 measures). In contrast, only five measures assessed the “involvement of family and
friends.” Two measures included one IOM-endorsed patient-centred care dimension, two measures had two
dimensions, seven measures had three dimensions, five measures had four dimensions, and four measures
had five dimensions. One measure, the Indicators (Non-small Cell Lung Cancer), covered all six IOM dimensions of
patient-centred care, but had adequate face/content validity only. Eighteen measures met the recommended adequacy
criteria for construct validity, 15 for face/content validity, seven for internal consistency, three for cross-cultural adaptation
and no measure for test-retest reliability.
Conclusions: There are no psychometrically rigorous PROMs developed with cancer patients that capture all six IOM
dimensions of patient-centred care. Using more than one measure or expanding existing measures to cover all six
patient-centred care dimensions could improve assessment and delivery of patient-centred care. Construction of new
comprehensive measures with acceptable psychometric properties that can be used with the general cancer population
may also be warranted.
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The Institute of Medicine has defined high quality health
care as the provision of appropriate services in a tech-
nically competent manner, and includes good communi-
cation, shared decision-making and is consistent with
patient values and preferences [1]. Optimizing the struc-
ture (e.g., hospital resources, number of staff ), processes
(e.g., interactions between health care providers and
patients, use of effective therapies) and outcomes (e.g.,
survival, quality of life) of health care services are crucial
to achieving high quality care [1]. In 2001, the IOM pub-
lished “Crossing the Quality Chasm” a broad framework
which recommended improvements to the following six
areas of healthcare in order to achieve high quality care:
safety; effectiveness; timeliness; efficiency; equity; and
patient-centredness [1]. Within the area of patient-
centredness, the IOM also endorsed Gerteis et al’s six
dimensions of patient-centred care [2] which state that
care must be: 1) respectful to patients’ values, prefer-
ences, and expressed needs; 2) coordinated and inte-
grated; 3) provide information, communication, and
education; 4) ensure physical comfort; 5) provide emo-
tional support—relieving fear and anxiety; and 6) in-
volve family and friends [1]. The IOM’s recognition of
patient-centredness as an indicator of quality acknowl-
edges the adoption of a whole-person orientation to
healthcare that goes beyond solely focusing on treat-
ment of the disease.
A variety of sources have been used to assess the qual-
ity of care that patients receive including administrative
databases, cancer registries, medical records, patient
self-reported measures, physician surveys, and pharmacy
and laboratory data [3]. However unlike other aspects of
quality, such as efficiency, patient self-report is arguably
the only way to assess constructs that relate to patient-
centredness. For instance, the severity of cancer pain
and levels of fatigue experienced by a patient can only
reliably be assessed by the patient themselves, and
self-report is widely recognised as the gold standard for
such assessments [4]. The value of obtaining patient
self-report data is further demonstrated by research
reporting that patients’ perceptions of quality of health
care have been associated with important medical and
psychological outcomes, including quality of life [5-8],
anxiety and depression [6-9]. Patients’ perceptions of
quality of care have also been associated with factors
that directly affect the effectiveness and efficiency of
health care such as the under-utilisation of treatments
[10-12] and mistrust of the medical system [13,14].
Patient-reported outcome measures (PROMs) that
have been designed to assess the quality of patient-
centred care include measures of: 1) satisfaction with
care; and 2) experiences of care. Satisfaction with care
measures investigate the extent to which an individual’shealth care experiences met his/her expectations [15].
However, a range of factors unrelated to the actual
health care that was delivered, such as differences
among patients’ expectation levels, can cause variability
in satisfaction ratings, which reduce their reliability for
widespread and ongoing monitoring of attempts to im-
prove patient-centred care [15]. In contrast, experiences
of care measures ask patients to indicate what actually
happened during the process of care delivery, and so are
less influenced by subjective patient expectations and
provide more detailed information to health care pro-
viders and systems about where quality improvements
are needed [16,17]. However, in order to accurately reflect
the quality of care received and identify variations in pa-
tients’ experiences, PROMs should meet recommended
psychometric criteria for reliability (internal consistency,
test re-test reliability), and validity (face, content, construct
validity) [18-24].
There are few existing reviews that have assessed the
psychometric properties of measures developed to iden-
tify patients’ experiences of care across a range of set-
tings and diseases [25-28]. Only one of these reviews
evaluated the psychometric properties of quality of care
measures designed specifically for cancer patients, but
focused on satisfaction measures [27]. Further, this re-
view [27] did not investigate the degree to which these
quality of care measures assessed the six IOM-endorsed
dimensions of patient-centred care [1].
This systematic review identified:
1) the degree to which PROMs developed to assess the
quality of patient-centred cancer care since the pub-
lication of the IOM’s “Crossing the Quality Chasm”
report in 2001 have addressed the IOM’s six en-
dorsed dimensions of patient-centred care [1]; and
2) the psychometric properties of these measures.
Methods
Search strategy and selection criteria
The electronic databases Medline, PsycINFO, Current
Contents, Embase, CINAHL and Scopus were searched to
retrieve published studies outlining the development of
PROMs designed to assess the quality of patient-centred
cancer care. Given the IOM’s Crossing the Quality Chasm
report was published in 2001 [1], databases were searched
between January 2001 and December 2011 inclusive. The
following combinations of keywords were used: (patient-
centred or patient-centered or quality of care or satisfac-
tion or experience*) AND (questionnaire* or survey* or
instrument* or measure* or scale* or tool*) AND (cancer*
or neoplasm* or oncol*). The use of an * in the keywords
allows words that contain that term to be captured in the
literature search. For example the keyword measure* will
identify articles that contain variations of that word such
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The reference lists of retrieved articles were also checked
to identify any additional relevant publications.
The inclusion criteria for this systematic review were
studies that:
(i) reported the development and psychometric
properties (reliability and validity) of new PROMs
designed to assess the quality of patient-centred
cancer care, or reported the validation of an existing
measure for use with a new population (e.g.
patient-centred care measure translated for use with
a Spanish cancer patient population). Given the
IOM’s recommendations were published in 2001
[1], studies describing the validation of an existing
measure were eligible only if the original PROM
was developed from 2001 onwards.
(ii) described PROMs specifically developed for use
with adult cancer patient populations (i.e., aged 18
years or older); and
(iii) were published in an English language peer-
reviewed journal.
Publications were excluded if they:
(i) were reviews, editorials, commentaries or protocol
papers;
(ii) reported qualitative research or used a Delphi
consensus process;
(iii) reported data from medical records, administrative
databases or cancer registries (i.e., patients were
not surveyed);
(iv) focussed on cancer screening only;
(v) predominately surveyed cancer patients under 18
years of age;
(vi) assessed the views of health professionals such as
oncologists, nurses, and general practitioners;
(vii) examined the perceptions of relatives and/or
caregivers;
(viii) included only cancer patients with advanced
cancer or those receiving end of life care; These
patients were excluded because the outcome
measures and care delivered to patients with
advanced cancer can be unique, reflecting the
specific goals of advanced disease and/or end-of-
life care [29].
(ix) reported only patient ratings of quality of care and/
or patient characteristics associated with quality of
care – i.e. did not develop a measure with the aim
of testing its psychometric properties; and
(x) validation of an existing measure that was not
eligible for the review (e.g. the original PROM was
developed prior to 2001). PROMs developed prior
to 2001 were excluded because it would have beenunreasonable to assess the degree to which such
PROMs addressed the IOM’s dimensions of patient-
centred care given the IOM recommendations were
published in 2001 [1].
Study and sample characteristics
The study and sample characteristics extracted from eli-
gible publications included: the name of the measure;
country of development; patient recruitment setting (e.g.
hospital, cancer registry); patient eligibility criteria; sam-
ple size; consent rate; participants’ socio-demographic
characteristics (e.g. mean age, gender, level of education,
employment status); and participants’ disease and treat-
ment characteristics (e.g. cancer type, cancer stage and/
or time since diagnosis, treatments received).
Items and subscales of measures
Information extracted about the characteristics of each
measure included: the type of measure (i.e. satisfaction
versus experiences); number of items; the type of re-
sponse scale, and the names and number of subscales.
Two coders (FT & SKR) independently examined each
of the PROMs’ items to determine whether or not the
PROM contained content that related to any of the
IOM’s six patient-centred dimensions and how many of
the six IOM-endorsed dimensions of patient-centred
care were covered [1]. At least one item in the PROM
needed to examine issues related to a particular IOM
patient-centred care dimension (as defined below) for
that area to be categorised as addressed. A conservative
approach was taken when deciding whether or not a
measure covered a particular dimension. For example, if
a measure included an item that examined whether a pa-
tient was provided with information on long-term side
effects, the measure was categorised as meeting the in-
formation and communication dimension, but not the
physical comfort dimension. The physical comfort di-
mension was classified as present only if items assessed
the provision of pain relief or the management of physical
symptoms. The criteria used to classify each patient-
centred care dimension, which are based on the definitions
outlined in the IOM’s “Crossing the Quality Chasm” report
[1], are described below. Only one aspect of the dimension
was needed for the PROM to be classed as covering that
patient-centred care dimension.
1) Respect for patients’ values, preferences, and
expressed needs
PROMs were classified as covering this dimension if
they assessed: a) whether care responded to the patient’s
cultural and other values, preferences and needs; b)
whether patients were given the opportunity to express
their views; c) whether patients were treated with re-
spect during care; and/or d) whether patients were
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their preferences [1].
2) Coordinated and integrated care
PROMs were rated as containing this dimension if they
asked: a) whether patient care was coordinated and inte-
grated; b) whether there was timely transfer of up-to-
date patient information between healthcare profes-
sionals; and/or c) whether patient transitions from one
healthcare setting to another went smoothly [1].
3) Provide information, communication, and education
PROMs met the criteria for this dimension if they exam-
ined whether health care professionals: a) communicated
with patients in a way they could understand; and/or b)
provided accurate information regarding care including
diagnosis, prognosis, treatment options, follow-up care
and support services, according to the patient’s preferred
level of information provision [1].
4) Physical comfort
PROMs were classified as covering this dimension if
they asked patients whether health care professionals: a)
promptly provided pain relief; and/or b) attended to the
patient’s physical symptoms and needs [1].
5) Emotional support
PROMs were categorised as meeting this dimension if
they assessed whether healthcare professionals: a) ad-
dressed the patients’ emotional and spiritual concerns,
such as anxiety, which could be experienced for a variety
of reasons including uncertainty about their disease, con-
cerns about the financial impact of treatment, or worrying
about the impact of the illness on their family [1].
6) Involvement of family and friends
PROMs were considered to have met this dimension if
they assessed whether: a) family and friends were in-
volved in the patient’s decision making and care accord-
ing to the patient’s preferences; and/or b) whether care
was responsive to the concerns of family and friends and
recognised their needs [1].
Two coders (FT & SKR) also independently examined
which PROMs covered all aspects within each of the
IOM dimensions. For instance in terms of the physical
comfort dimension, PROMs that included items that ad-
dressed both of the following criteria were identified: a)
promptly provided pain relief; and b) attended to the pa-
tient’s physical symptoms and needs.
Psychometric properties of measures
The psychometric properties of each measure were
assessed against the same criteria used by Clinton-
McHarg and colleagues in their review of instrumentsdesigned to measure the psychosocial health of adoles-
cent and young adult cancer survivors [30]. The psy-
chometric criteria are described below.
Internal consistency
A measure was coded as having acceptable internal
consistency if correlations for the total scale and each sub-
scale were calculated [19] and a Cronbach’s alpha >0.70
(continuous or dichotomous scales) or Kuder-Richardson
20 (KR-20) >0.70 was reported for the total scale and each
sub-scale [18,19].
Test-retest reliability
Measures were recorded as having adequate test-retest
reliability if the instrument had been administered twice
to the same sample and: 1) the second administration
occurred within 2-14 days of the first administration
[20]; and 2) correlations for the total scale, subscales and
items were calculated [21] and the agreement between
scores achieved a Cohen’s kappa co-efficient (κ) > 0.60
(nominal or ordinal scales) [19] or Pearson correlation coef-
ficient (r) > 0.70 (interval scales) [18,19] or intraclass correl-
ation coefficient (ICC) >0.70 (interval scales) [18,19].
Face validity
Measures were considered to have face validity if both
those who administered it, and those who completed it,
agreed it appeared to measure what it was designed to
measure [22].
Content validity
A measure was reported to have adequate content valid-
ity if the following processes were described: 1) how the
items were developed or selected [18,19]; 2) how and by
whom the content was assessed [18,19]; and 3) if modifi-
cations to the content were needed that the revisions ad-
dressed the issues identified [18,19].
Construct validity
Each measure was assessed as having adequate construct
validity if any of the following tests were performed: 1)
comparison with other existing measures [19] resulting
in Pearson correlation coefficients of (r) >0.40 (conver-
gent validity) or (r) < 0.30 (divergent validity) [23]; 2)
comparison of scores on the measure differ significantly
between groups with known differences (discriminative
validity) [18]; or 3) factor analysis [19] with Eigenvalues
set at > 1 [24].
Cross-cultural adaptation
A measure was considered to have adequate cross-
cultural adaptation if a conceptually and linguistically
equivalent version of the original form confirmed the
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ure [18].
Coding process
Two authors (FT & SKR) independently assessed all po-
tentially relevant publications to determine whether they
met eligibility for inclusion in the review. There was 84%
agreement between the two coders’ ratings. Where dis-
crepancies emerged, inconsistent ratings were discussed
between the coders until consensus was reached. Both
coders also independently extracted information for the
Tables from included publications to ensure accuracy.
The coders then compared the information extracted




A total of 671 publications were identified from the elec-
tronic database searches and publication reference lists.
Of these, 161 publications were reviews, editorials, com-
mentaries or protocol papers, 40 reported qualitative re-
search and 16 used a Delphi consensus process and were
excluded. A further 108 papers reported data from med-
ical records, administrative databases or cancer registries
and 53 focussed on cancer screening only and were re-
moved. Of the 293 remaining publications, 48 assessed
the views of health professionals such as oncologists,
nurses, and general practitioners, 44 focussed on the
perceptions of relatives or caregivers, one related to can-
cer patients aged under 18 years, and 37 focused on an
advanced cancer population and/or those receiving end-
of-life care and were excluded. Of the remaining 163
publications that surveyed adult cancer patients, 121 ex-
amined the prevalence of features of care and/or charac-
teristics associated with patient experiences and 14
validated an existing measure that was not eligible for
the review (e.g. the original PROM was developed prior
to 2001). One paper that reported the development of
the EORTC OUT-PATSAT35 was published in French
and therefore excluded [31]. This left 27 papers that
reported the development of an instrument and its psy-
chometric properties with an adult cancer patient popu-
lation, or reported the psychometric properties of a
re-validated measure for use with a new population. In
these papers, 21 unique PROMs were described (see
Figure 1).
Setting and Sample Characteristics
Table 1 provides a detailed description of the setting and
sample characteristics of the eligible studies [32-55]. Six
studies were conducted in the USA [32,35,42-44,47], five
in The Netherlands [37,39,40,50,52], three in England
[41,49,54], two in France [53,55], and one in Australia[33], Canada [34], Europe and Asia [38], Germany [46] and
Japan [48]. Seventeen studies recruited cancer patients from
hospitals or treatment centres [33,34,38-44,46-50,53-55],
whereas only one study recruited patients via a population-
based cancer registry [32]. The sample sizes in each study
ranged from 82 to 2659 cancer patients and the consent
rates varied from 43% to 85%. Thirteen studies included
more than one cancer type [32-35,38,41,43,44,46-48,52,55].
Patient-centred care instruments
The names of the PROMs included in the review are
shown in Tables 1, 2, 3, 4 and 5. As shown in Table 2,
15 measures examined patients’ experiences of care
[32,33,37,39-44,48-50,52,53,55] while 6 measured satis-
faction [34,35,38,46,47,54]. The number of items for
each measure ranged from 15 to 152, and the number of
subscales ranged from 1 to 15. The type of response
scales varied across the different instruments. The num-
ber of IOM-endorsed patient-centred care dimensions
[1] that were included in each measure were as follows:
two measures included one dimension [35,54], two mea-
sures had two dimensions [42,46], seven measures had
three dimensions [34,39,41,47,48,50,55], five measures
had four dimensions [32,33,37,49,53], and four measures
had five dimensions [38,43,44,52]. Only one measure,
the Indicators (Non-small Cell Lung Cancer) measure,
covered all six dimensions of patient-centred care [40].
Table 3 summarises the PROMs that addressed each of
the IOM-endorsed patient-centred care dimensions.
Figure 2 illustrates the frequency with which the six
IOM-endorsed patient-centred dimensions were included
across the 21 measures. “Information, communication and
education” was the dimension most commonly included
(19 measures). In contrast, only five measures assessed the
“involvement and wellbeing of family and friends”. Thirteen
measures addressed all the IOM criteria for the emo-
tional support dimension [32-34,37-41,43,48,52,53,55],
8 measures for information, communication and edu-
cation [32,37,47,48,50,52,54,55] and one measure for
physical comfort [44]. None of the measures addressed
all the IOM criteria within the dimensions of respect
for patient values, preferences and needs; coordinated
and integrated care; and involvement and wellbeing of
family and friends.
Psychometric properties of instruments
A description of the psychometric properties for each
PROM is reported in Table 4.
Internal consistency
Seven of the 21 measures met the criteria considered ad-
equate for internal consistency by reporting a Cronbach’s
alpha >0.70 for both the total scale and each sub-scale
[33,42,43,46-48,55]. Of the 13 studies that reported
Potentially relevant publications identified from 
Medline, PsycINFO, Current Contents, Embase, 
CINAHL and Scopus for years 2001-2011
(Publications n=671)
Excluded, research methodology did not meet 
inclusion criteria 
(Publications n=378)
- Literature reviews, editorials, commentaries 
and protocols (n=161)
- Reported qualitative research (n=40)
- Used a Delphi process (n=16)
- Focused on cancer screening (n=53)
- Used medical record data (n=108)
Publications limited to self-report surveys
(Publications n=293)
Excluded, sample did not meet inclusion criteria
(Publications n=130)
- Patients less than 18 years old (n=1)
- Patients with advanced cancer (n=37)
- Surveyed health providers (n=48)
- Surveyed caregivers (n=44)
Publications limited to surveyed adult cancer 
patients
(Publications n=163)
Excluded, did not describe development of 
patient-centred measures
(Publications n=121)
- Reported prevalence data only (n=121)
27 publications eligible for review
21 unique measures identified
Publications limited to development and 
validation of original patient-centred measure
(Publications n=42)
Excluded, ineligible timeframe or language
(Publications n=15)
- Re-validation of measure that was not eligible 
for review (n=14)
- Publication not in English (n=1)
Figure 1 Flowchart of methods used to identify relevant publications.
Tzelepis et al. BMC Cancer 2014, 14:41 Page 6 of 32
http://www.biomedcentral.com/1471-2407/14/41Cronbach’s alpha only for the PROMs’ subscales, six of
these measures showed all subscales had a Cronbach’s
alpha >0.70 [34,35,44,52-54].
Test-retest reliability
None of the five measures that examined test-retest
reliability [33,35,38,49,53] met recommended adequacy
criteria of a second administration within 2-14 days ofthe first administration [20] and an adequate agreement
between the two administrations on scores for the total
scale, subscales and items [18,19].
Face/content validity
Fifteen measures met the criteria considered adequate
for face validity and content validity [33,35,37-41,
43,44,48-50,52,53,55].
Table 1 Sample characteristics of studies that have developed PROMs assessing quality of patient-centred cancer care
Measure Sample
size








Read English, diagnosed with leukaemia
or bladder or colorectal cancer between
June 1999-May 2001 (i.e., 2-5 years before
study enrolment), at least 20 years old at
diagnosis, have received cancer treatment,
have the cancer of interest as their first
cancer diagnosis, not have any other cancer
between their initial diagnosis and the start
of the study, have no objections from their

































686 - Sample 1 (n = 245): Patients were in follow-up
for any cancer that had been treated between
3 to 12 months previously, had sufficient
English and were not cognitively impaired
and were not receiving end of life care.
Sample 1: Six centres
(2 metropolitan
& 4 regional).
Total participants: Colorectal: 82.5% 96% surgery
46.8% women Gynaecological: 7.6% 40.5% chemotherapy

















Sample 2 (n = 441): Patients with a newly






540 - - Ambulatory setting of
regional cancer centre,
Canada.
53% women Breast: 19.1% -




Head and neck: 11.3%
Gynecologic: 11.2%
Lung: 10.4%



















Table 1 Sample characteristics of studies that have developed PROMs assessing quality of patient-centred cancer care (Continued)
Cancer Therapy Satisfaction
Questionnaire (CTSQ) [35,36]
361 - Provided written informed consent, aged
18 years or older, read and write in English,
available for follow-up evaluation, actively
receiving more than one cycle of first- or
second-line chemo, biological or hormonal
therapy for early or advanced cancer,




63.2% women Breast: 37.9% First-line of therapy:
48.8%
Mean age: 60.7 years Colorectal: 33.5%










Breast Care (CQI-BC) [37]
731 63% Older than 18 years, having received breast
care in the last 24 months, not being
approached in the past for CQI surveys.
Selected from claims
data of four health
insurance companies,
The Netherlands.
99.7% women Breast cancer: 57% -
30% aged between
55 and 64 years
Benign breast disorder:
38%







647 84.9% Diagnosed with cancer, aged 18 years or
older, hospitalized for at least three days,








59% women Breast: 35.1% Current or planned
treatment:
Median age: 57 years Gastro-intestinal: 17.2% 55% surgery
21% university educated Gynaecologic: 10%
73.6% married/defacto Head and neck: 7.3% 40.8% chemotherapy
40.5% full time employed Genito-urinary: 7.1% 3.2% surgery and
chemotherapy
Haematological: 6.5%








Median of 15 weeks
since diagnosis.
Indicators (Head & Neck
Cancer) [39]
158 84% Patients with head and neck cancer newly
diagnosed between May to December 2003
Selected from clinic
lists at a university
hospital, The
Netherlands
27% women Head & neck cancer. First treatment:
Mean age: 62 years Larynx and hypharynx:
38%
Operation: 56%

















Table 1 Sample characteristics of studies that have developed PROMs assessing quality of patient-centred cancer care (Continued)
Cavity of the mouth:
36%
Other: 26% Chemotherapy: 7%
-
Indicators (Non-small
Cell Lung Cancer) [40]
100 76% Patients newly diagnosed with non-small




34% women Non-small cell lung
cancer.
-
Mean age: 66 years Stage IV: 24%
Medical Care Questionnaire
(MCQ) [41]
Phase Phase 3: Adult patients from all tumor groups attending
the Medical Oncology Unit, could read and
understand English, were not exhibiting overt
cognitive dysfunction or signs of distress.
A regional hospital,
England.
Phase 3: Phase 3: -
3: 200 70% 81% women Gynecological: 38%
Phase 4: 477 Phase 4: 79.6% 42% aged 45-59 years Breast: 26.5%
74% married/de facto Genitourinary: 16.5%
13% employed full time Sarcoma: 5.5%
Gastrointestinal: 4.5%
Phase 4: Melanoma: 1%
74.2% women Other: 8%
40.9% aged 45-59 years
75.1% married/de facto Phase 4:







Modified Version of the
Perceived Involvement in
Care Scale (M-PICS) [42]
87 74% Females aged 18 years or older, confirmed
diagnosis of breast cancer, reported pain of
at least moderate intensity (score ≥4 on the
Brief Pain Inventory’s Worst Pain Intensity
item) over prior two weeks, absence of any








100% women Breast cancer. 89.7% chemotherapy
Mean age: 50.4 years Stage I: 12.6% 43.7% radiation
therapy
31% Caucasian Stage II: 24.1%
50.6% married/partnered Stage III: 13.8%






Quality of Nursing Care
Scale (OPPQNCS) [43]
436 - 18 years or older, registered with the receptionist
on the days of data collection, had received
cancer nursing care in the clinic or hospital, not




66% women Breast: 40% In active treatment
Mean age: 54.8 years Melanoma: 9%
93% white Lung: 6%
























Pain Care Quality Survey
(PainCQ) [44,45]
109 - 18+ years of age, inpatients on one of the
designated units with an expected stay of
more than 24 hours, diagnosis of cancer,
surgery for cancer, a suspected cancer
diagnosis or a hematological disorder and
a positive response to screening regarding
the presence of pain, cognitively and











Mean age: 53.1 years






66.1% married/partnered Prostate and genitourinary:
11.9%
25.7% college graduate
Colorectal: 10.1% Treatment of cancer:
8.3%
Lung: 7.3%





34.9% local or regional
41.3% advanced cancer
PASQOC questionnaire [46] 2659 78.6% Aged 18 years or older, the presence of
any cancer suitable for outpatient
treatment, read and write in German, mentally





3 hospital day clinics,
Germany.
56% women Breast: 22.9% 80.9% chemotherapy
Mean age: 61.7 years Intestine: 19.8% 58.0% surgery








891 - Abnormal breast, cervical, colorectal and prostate
cancer test finding or a new diagnosis of these
cancers without any prior history of cancer
treatment other than non-melanoma skin










81.3% women Breast: 64.2% -
Mean age: 51.4 years Cervix: 10.8%
43.2% white Colorectal: 12.0%
40.4% married/defacto Prostate: 12.6%






147 74% Patients with cancer who were aware of their
cancer diagnosis, met their doctor more than
once and did not have a debilitating condition.
A hospital, Japan. 66.7% women Breast cancer: 50.3% -
Mean age: 57.6 years Gastric cancer: 30.6%























for Patients (PCQ-P) [49]
865 69.2% Patients diagnosed with, or treated for prostate
cancer within the past two years, who were
not too ill to participate.
5 hospitals, England 100% male Prostate cancer -





276 43% Experience with any type of surgery for breast
cancer 3 -15 months before the start of the study,
age older than 17 years and mental competence
as judged by the breast nurse.
5 hospitals, The
Netherlands.
100% women Breast cancer 54% lumpectomy




16% diagnosed 3-6 months
ago, 47% 7-12 months
ago, 34% 13-18 months




QUOTEchemo [52] 345 59.3% 60 most recent patients from each hospital who
were new to chemotherapy, aged 18 years or




67% women Breast: 47.2% 16.2% chemotherapy
only
Mean age: 55.7 years Digestive-gastrointestinal:
21.5%
79% lived with partner 74.5% chemotherapy
& surgery
28% highly educated Haematologic: 10.6%
Lung: 9.7%




Other: 1.8% 21.1% chemotherapy
& hormone replacement
therapy






REPERES-60 [53] 820 84% A first diagnosis of invasive non-metastatic breast
cancer, at least two contacts for cancer with one
of the health professionals in one of the two
regions between diagnosis and the first year of




100% women Breast cancer. -









82 76% Newly diagnosed patients with head and neck
cancer.
























Table 1 Sample characteristics of studies that have developed PROMs assessing quality of patient-centred cancer care (Continued)
31% surgery and
radiotherapy
Mean age: 60 years Stages I and II:
approximately 50%;









SAT-RAR [55] 297 55.8% Aged> 18 years, curative irradiation and satisfactory
general status (<3 on WHO performance scale).
16 centers, France. Breast cancer (n = 98): Non-small cell lung
cancer.
100% radiotherapy
Mean age: 56 years Respiratory gating:
44% (breast cancer)





cancer (n = 199):





Mean age: 65 years
15% women
Mean days hospitalized:


















Table 2 Measurement features of PROMs and included IOM-endorsed patient-centred care dimensions
Measure Satisfaction/
experience




Experiences 33 Not a problem, A small problem,
A big problem.
Getting needed care Emotional support
Timeliness of care Information & communication
Never, Sometimes, Usually,
Always.
Waiting time in physician’s office Integrated & coordinated care
Information exchange Respectful to patients’ values
Physicians’ affective behavior
Physicians’ knowledge
On time, < 15 minutes, 16-30 minutes,
31-45 minutes, > 45 minutes.
Interaction with nurses
Interaction with office staff
Health promotion
Coordination of care
Poor, Fair, Good, Very good, Excellent. Overall rating of care
Yes definitely, Yes somewhat, No.
0 (worst doctor possible) to 10 (best
doctor possible)
Definitely yes, Probably yes, Not sure,




Experiences 20 Strongly disagree, Disagree, Neutral,
Agree, Strongly agree.
Communication Emotional support
Navigation Family & friends
Never, Rarely, Sometimes, Frequently,
Always.
Information & communication




Satisfaction 24 5 point scale from Not important (0) to
Very important (4).
Information importance Emotional support
Information satisfaction Information & communication




Satisfaction 16 5 point scale with 1 representing the
worst response and 5 representing
the best response.
Expectation of therapy Respectful to patients’ values
Feelings about side effects
Satisfaction with therapy
Consumer Quality Index
Breast Care (CQI-BC) [37]
Experiences 152 (118 items related
to patients’ experiences)




Yes, No. Conduct of general practitioner Integrated & coordinated care
Conduct of nurses Respectful to patients’ values






















Table 2 Measurement features of PROMs and included IOM-endorsed patient-centred care dimensions (Continued)
Conduct of professionals during
radiotherapy
Information on radiotherapy












Satisfaction 32 Poor, Fair, Good, Very good,
Excellent.
Doctors’ technical skills Emotional support
Doctors’ interpersonal skills Information & communication
Doctors’ information provision Integrated & coordinated care
Doctors’ availability Physical comfort





Other hospital staff interpersonal






Indicators (Head & Neck
Cancer) [39]
Experiences 23 specific indicators
for patients
- Patient-oriented quality of care Emotional support
Organisational quality of care Information & communication
Medical/technical quality of care Integrated & coordinated care
Indicators (Non-small Cell
Lung Cancer) [40]
Experiences 56 1 = Not done, 2 = Done, but
inadequately, 3 = Done adequately,
4 = Done excellently.
Access Emotional support
Follow up Family & friends
Communication and respect Information & communication
Patient & family involvement Integrated & coordinated care
Yes, No Information Physical comfort

















Table 2 Measurement features of PROMs and included IOM-endorsed patient-centred care dimensions (Continued)
Physical support
Emotional & psychosocial support
Medical Care Questionnaire
(MCQ) [41]
Experiences 15 - Communication Emotional support
Preferences Integrated & coordinated care
Coordination Respectful to patients’ values
Modified Version of the
Perceived Involvement
in Care Scale (M-PICS) [42]
Experiences 20 1 = All the time to 5 = Never. Health care provider information Information & communication
Patient information Respectful to patients’ values
Patient decision making
Health care provider facilitation
Oncology Patients’
Perceptions of the
Quality of Nursing Care
Scale (OPPQNCS) [43]
Experiences 40 (and 18-item short
form created)
1 = Never to 6 = Always, Didn’t matter,
Don’t know.
Responsiveness Emotional support
Individualization Family & friends
Coordination Information & communication
Proficiency Integrated & coordinated care
Respectful to patients’ values
Pain Care Quality Survey
(PainCQ) [44,45]
Experiences 33 1 = Strongly disagree to 6 = Strongly
agree.
PainCQ-Interdisciplinary scale: Family & friends
Partnership with healthcare team Information & communication
Comprehensive interdisciplinary
pain care
Integrated & coordinated care
Physical comfort
PainCQ-Nursing scale: Respectful to patients’ values
Being treated right
Comprehensive nursing pain care
Efficacy of pain management
PASQOC questionnaire [46] Satisfaction 120 Nominal or ordinal scales and some
interval scales
5 dimensions reported Information & communication
Patient-provider relationship Respectful to patients’ values
Premises
Information on diagnosis & treatment
Information on treatment consequences
Relationship between patient & nurse
Patient Satisfaction with
Cancer Care [47]
Satisfaction 18 1 = Strongly Agree to 5 = Strongly
Disagree
1 component structure – satisfaction
with cancer care
Information & communication
Integrated & coordinated care




Experiences 27 1 = Strongly Disagree, 3 = Neutral,
5 = Strongly Agree.
Acceptive Emotional support
Patient-centered Information & communication


















Table 2 Measurement features of PROMs and included IOM-endorsed patient-centred care dimensions (Continued)
Prostate Care Questionnaire
for Patients (PCQ-P) [49]
Experiences 106 (Sections A-E). Various scales – please see
reference [63]
Information from additional file 1 Information & communication
Section A: GP visits and referral Integrated & coordinated care
Explanation Physical comfort
Experience of referral Respectful to patients’ values
Taking the problem seriously


















QUOTE Breast Cancer [50,51] Experiences 33 Performance: Patient education regarding aspects
related to postoperative treatment
Information & communication
Never, Sometimes, Usually, Always. Integrated & coordinated care
Services by the breast nurse Respectful to patients’ values
Yes, No. Services by the surgeon
Patient education regarding activities
at home
Not applicable/I do not know added
to a subset of items.
Patient education regarding aspects
related to preoperative treatment
Importance:
Not important, Fairly important,
Important, Extremely important.
QUOTEchemo [52] Experiences 67 Performance: Treatment-related information Emotional support

















Table 2 Measurement features of PROMs and included IOM-endorsed patient-centred care dimensions (Continued)
Importance: Rehabilitation information Information & communication
Coping information Physical comfort
Not important, Fairly important,
Important, Very important.
Interpersonal communication Respectful to patients’ values
Tailored communication
Affective communication
REPERES-60 [53] Experiences 60 Bad, Fair, Good, Very good, Excellent. Access to primary care Emotional support
Access to secondary care Information & communication
Completely agree, Agree generally,
No marked opinion, Do not really
agree, Do not agree at all.
Competence and communication
skills of primary care doctors
Integrated & coordinated care
Competence of secondary care
doctors
Respectful to patients’ values
Communication skills of secondary
care doctors
Bad, Fair, Good, Very good, Excellent,
Not concerned.
Choice among different doctors
Human qualities of doctors
Global satisfaction
Cover for medical expenses
Listening abilities and information
provided by doctors







Satisfaction 21 Too much, About right, Too little,
None wanted.
Satisfaction with the amount and
content of information
Information & communication
Very satisfied, Satisfied, Neither,
Dissatisfied, Very dissatisfied.
Satisfaction with the form and
timing of the information received
SAT-RAR [55] Experiences 23 Poor, Fair, Good, Very good,
Excellent.




Not at all, A little, Quite a bit, Very
much.
Global satisfaction Physical comfort
Treatment experience
Poor, Moderate, Good, Very good,
Excellent.


















Table 3 IOM patient-centred care dimensions captured by PROMs













APECC [32] √ √ √ √
Cancer Care Coordination Questionnaire for
Patients [33]
√ √ √ √




CQI-BC [37] √ √ √ √
EORTC IN-PATSAT32 [38] √ √ √ √ √
Indicators (Head & Neck Cancer) [39] √ √ √
Indicators (Non-small Cell Lung Cancer) [40] √ √ √ √ √ √
MCQ [41] √ √ √
M-PICS [42] √ √
OPPQNCS [43] √ √ √ √ √
PainCQ [44,45] √ √ √ √ √
PASQOC questionnaire [46] √ √
Patient Satisfaction with Cancer Care [47] √ √ √
Perceived Physician’s Communication Style
Scale [48]
√ √ √
PCQ-P [49] √ √ √ √
QUOTE Breast Cancer [50,51] √ √ √
QUOTEchemo [52] √ √ √ √ √
REPERES-60 [53] √ √ √ √
SCIP [54] √
SAT-RAR [55] √ √ √
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Eighteen measures met the criteria for adequate con-
struct validity [32,33,35,37,38,41-44,46-50,52-55]. Six-
teen measures conducted factor analyses [32,33,35,
37,41-44,46-50,52,53,55] (although only seven reported
eigenvalues) [33,41,44,47,48,50,53], nine measures ex-
amined convergent validity (r >0.40) or divergent valid-
ity (r < 0.30) with existing instruments [35,38,42,
46,47,49,52-54] and six measures demonstrated signifi-
cant differences on scores between known groups
[35,38,41,42,53,55].
Cross-cultural adaptation
Three measures were re-validated with non-English speak-
ing populations. The EORTC IN-PATSAT32 was validated
with Sri Lankan cancer patients [56]; the Modified version
of the Perceived Involvement in Care Scale (M-PICS) was
validated with Lithuanian cancer patients [57]; and the
Oncology Patients’ Perceptions of the Quality Nursing
Care Scale (OPPQNCS) was validated with Turkish cancer
patients [58].Table 5 summarises which PROMs met the psycho-
metric criteria considered adequate, as described above.
Psychometric properties of PROMs containing all six IOM
patient-centred care dimensions
The Indicators (Non-small Cell Lung Cancer) measure
[40] was the only PROM that contained items covering
all six IOM dimensions of patient-centred care. This
measure met the criteria considered adequate for face/
content validity, but not for any other psychometric cri-
teria evaluated in this review.
Discussion
This is the first review to identify how many of the six
IOM-endorsed dimensions of patient-centred care [1]
are covered in existing PROMs assessing the quality of
cancer care. Our findings demonstrate that since the
publication of the IOM’s Crossing the Quality Chasm re-
port in 2001 [1], only one of 21 patient-centred cancer
care instruments, the Indicators (Non-small Cell Lung
Cancer) measure, included questions relating to the six
Table 4 Psychometric properties of PROMs assessing quality of patient-centred cancer care











All items underwent cognitive
testing with nine cancer
survivors to ensure that the
questions and response options
were understandable and
related to the concept being
measured.
Confirmatory factor analysis
indicated a reasonably good fit
for the 10-factor model (com-
parative fit index = 0.93).





























Questionnaire for Patients [33]
Literature review undertaken to
identify relevant issues and
existing instruments and focus
groups and semi-structured in-
terviews with 24 cancer patients
and carers and 29 clinicians.
Draft questionnaire was
reviewed by clinicians and re-
searchers to assess face validity
and clarity of wording.
Exploratory factor analysis.
Principal factor method followed
by a promax rotation.
- - Total scale: α=.88 Sample 1: 119
patients completed
the survey twice -
mailed 2 weeks






α=.73Factor loadings >.40 with the
exception of one item (0.37).
Kappa for individual
items ranged from
0.29 to 0.69. Four
items with values






Literature review and extensive
qualitative interviews with
cancer patients. Tool was field-




















Table 4 Psychometric properties of PROMs assessing quality of patient-centred cancer care (Continued)
tested with 10 cancer patients
who completed tool and pro-
vided feedback about its clarity






Interviews with 70 oncology
patients, 4 oncology nurses and
7 physicians. Focus groups with
14 oncology nurses. Content
validity tested with 30 patients
who completed the survey and
were interviewed, followed by
retesting in an additional 10
patients.
Exploratory factor analysis using
oblique promax rotation.
Cancer stage (I,






































Consumer Quality Index Breast
Care (CQI-BC) [37]
Three focus groups with 27
breast cancer patients, existing
Dutch questionnaires on breast
care and key stakeholders’ input
used for questionnaire
development.



































































EORTC cancer in-patient satisfac-
tion with care measure (EORTC
IN-PATSAT32) [38]
Adapted from existing patient
satisfaction questionnaires
(Comprehensive Assessment of
Satisfaction with Care and
EORTC QLQ-SAT32) [64,65], as
well as interviews with oncology
specialists and cancer patients.
- Age (less than 57
years, 57 years or
more) P <0.05
for 4 subscales.
Oberst Patients’ Perception of
Care Quality and Satisfaction






































































(yes, no) P <0.05
for 7 subscales.





















consensus procedure based on
evidence-based guidelines and
sought opinions of 15 profes-
sionals and 30 patients with
head and neck cancer.
- - - - - -
Indicators (Non-small Cell Lung
Cancer) [40]
Recommendations for patient-
centred care extracted from clin-
ical guidelines and conducted
semi-structured interviews with
30 head and neck cancer pa-
tients and 7 patient representa-
tives from the Dutch national
association of patients with lung
cancer. Two researchers trans-
lated recommendations into in-
dicators which were considered
by a panel of four researchers.






































Literature review of existing
instruments, modification (items
removed, reworded, generated)
of an existing instrument by an
expert panel (3 medical
oncologists and one oncologist
in training) using a consensus
procedure, instrument
administered to 200 oncology
outpatients and then refined.
Exploratory factor analysis using














Factor loadings >.40 Preferences:
α=.84
Eigenvalues > 1 Coordination:
α=.75
Modified Version of the
Perceived Involvement in Care
Scale (M-PICS) [42]
Literature review and
consultation with pain clinicians
guided augmentation and
addition of items on the original
Perceived Involvement in Care
Scale (PICS).
Exploratory factor analysis –
principal components analysis
with oblique rotation.
Age P<0.01 for 1
subscale.


















Mental Health Inventory Patient
information: α=
.82
3 correlations <.30 Patient decision
making: α= .80
Medical Outcomes Study Short-







Medical Outcomes Study Short-







of the Quality of Nursing Care
Scale (OPPQNCS) [43]
Interviews with cancer patients
about their perceptions of
nursing care, items and
subscales generated from this
qualitative work, an expert
methods consultant evaluated
Exploratory factor analysis –
principal components analyses
with promax (oblique) rotation.


























Table 4 Psychometric properties of PROMs assessing quality of patient-centred cancer care (Continued)
items for clarity and relevance
and a nine-member expert rater
panel consisting of 5 cancer pa-
tients, a nurse, a nurse re-
searcher, the executive director
of a patient advocacy group and






Factor loadings >.40 Proficiency: α=
.95
Pain Care Quality Survey
(PainCQ) [44,45]
Conducted 33 qualitative
interviews with cancer patients
in pain. Items were constructed
using this qualitative work,
existing tools, recommendations
for item development in the
literature, and consultation with
a national expert in tool
development. Two panels of
pain and quality experts
reviewed items (removed,
reworded or added items).
Cognitive interviews were then
undertaken with 39 hospitalized
cancer patients reporting pain.
Exploratory factor analysis –
















Factor loadings >.40 Comprehensive
nursing pain
care: α=.77
Eigenvalues > 1 Efficacy of pain
management:
α=.87
PASQOC questionnaire [46] Existing survey re-designed and
content similar to other surveys.
Focus group discussions with 29
patients in four centres.
Factor analysis - Short Form-36 (SF-36) correla-




Pre-testing the questionnaire for
appropriateness of the questions
and length with 280 patients
from 14 centres.
Factor loadings >.40 with the































Table 4 Psychometric properties of PROMs assessing quality of patient-centred cancer care (Continued)
Patient Satisfaction with Cancer
Care [47]
Item pool based on literature
review and existing measures,
expert feedback, group
discussion and consensus.
Factor analysis – principal
components analysis
- Communication and Attitudinal
Self-Efficacy – Cancer 1 correl-
ation >.40 (sample 2).
Total scale: α=






Communication Style Scale [48]
Initial item pool created from
literature review and 25 cancer
patients’ opinions about the
physician’s communication
style.114 nurses assessed the
content validity of items. Items
pre-tested with 70 breast cancer
patients.
Factor analysis using varimax
procedure.
- - Total scale: α=
.95
- -
Factor loadings >.40 Acceptive: α=.90




Prostate Care Questionnaire for
Patients (PCQ-P) [49]
Initial items developed through a
literature review and interviews
with patients and service providers.
Semi-structured interviews with 20





- National Centre for Social
Research Shortened
Questionnaire






Factor loadings for each section
of 0.3 and higher presented in
an additional file.
Sections B & C Section B: α=.63
r <.30 Section C: α=.77
Sections D & E r >.40 Section D: α=.80












QUOTE Breast Cancer [50,51] Based on eight focus groups
with 72 breast cancer patients
and concept mapping sessions
with 67 breast cancer patients a
pilot questionnaire was
developed. Two researchers
categorised and reduced the
aspects of care identified.
Exploratory factor analysis (i.e.,
principal axis factoring) –
oblique rotation.
Age (18-49, 50-









Factor loadings >.40 except for













































QUOTEchemo [52] Items developed via existing
measure, literature review and 5
focus groups (n=33) as well as
individual interviews with 5
cancer patients. 10 coders
categorised the items into the
seven dimensions.
Confirmatory factor analysis. - QUOTEchemo Importance with: Performance: - -































Impact of Event Scale: Prognosis
information: α=
.76
- Intrusion 7 correlations r <.30 Rehabilitation
information: α=
.86





























REPERES-60 [53] Literature review and two focus
groups with 30 breast cancer
patients used to generate items
and identify domains. Adapted
existing Consumer Satisfaction
Survey and developed new
items based on patient focus
groups and experts’ input. Test
version of questionnaire tested
with breast cancer patients to
assess understanding and
comprehensiveness of items,
which led to minor alterations.
Principal components factor
analysis (varimax rotation).
Age (less than 58
years, 58 years or
older)




sent retest 1 week
later.
-







































































Information Profile (SCIP) [54]
Four items derived from
Satisfaction with Information
About Medicines Scale (SIMS)
and additional items from
patient interviews.













SAT-RAR [55] Review of the literature,
selection and formation of items




10 patients to evaluate rele-
vance, content validity and com-
prehensibility of items, survey
reviewed by clinicians in the
study.
Exploratory factorial analysis with







- Total scale: α=.86 - -








Most factor loadings >.40,

























































Cancer Care Coordination Questionnaire for
Patients [33]
√ √ √
Cancer Patient Information Importance and
Satisfaction Tool [34]
CTSQ [35,36] √ √ √ √
CQI-BC [37] √ √
EORTC IN-PATSAT32 [38] √ √ √ √
Indicators (Head & Neck Cancer) [39] √
Indicators (Non-small Cell Lung Cancer) [40] √
MCQ [41] √ √ √
M-PICS [42] √ √ √ √ √
OPPQNCS [43] √ √ √ √
PainCQ [44,45] √ √
PASQOC questionnaire [46] √ √ √
Patient Satisfaction with Cancer Care [47] √ √ √
Perceived Physician’s Communication Style
Scale [48]
√ √ √
PCQ-P [49] √ √ √
QUOTE Breast Cancer [50,51] √ √
QUOTEchemo [52] √ √ √
REPERES-60 [53] √ √ √ √
SCIP [54] √
SAT-RAR [55] √ √ √ √
Figure 2 Frequency of IOM-endorsed patient-centred care dimensions across 21 measures.
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this measure only met the criteria considered acceptable
for face/content validity. Further psychometric testing of
the Indicators (Non-small Cell Lung Cancer) measure is
required before more definitive conclusions can be
drawn about its reliability and validity.
Across measures, the most commonly included patient-
centred care dimensions were “information, communi-
cation and education” (19 of 21 measures) followed
by “respectful to patients’ values, preferences, and expressed
needs” (16 of 21 measures). In contrast, only seven mea-
sures examined patient’s perceptions of “physical comfort”
and five assessed the “involvement and wellbeing of family
and friends.” Possible explanations for the lesser focus on
issues related to family and friends could include: 1) re-
searchers/health professionals perceiving issues related to
information and communication as the most important fea-
tures of patient-centredness; 2) that the patients and survey
developers involved in item selection only wished to focus
on specific aspects of care; and 3) issues related to family
and friends are considered a less crucial feature of cancer
care. Furthermore, the measures may not have adequately
captured the IOM’s six dimensions of patient-centred care
because they were not developed for that purpose. For ex-
ample, a measure’s objective may have been to focus solely
or primarily on physical comfort, rather than to address the
IOM’s six dimensions of patient-centred care. Nevertheless,
the lack of PROMs that included all six IOM dimensions of
patient-centred care [1] limits the potential of these existing
measures to capture the whole-person orientation of health
care and is likely to result in an incomplete representation
of the quality of care provided to cancer patients.
Improvements to the reliability of existing patient-
centred care PROMs and better reporting of their in-
ternal consistency, are needed. Only seven of the 21
measures met the criteria considered adequate for in-
ternal consistency by reporting a Cronbach’s alpha >0.70
for the total scale and each sub-scale [33,42,43,46-48,55].
A further six measures showed that all subscales had
a Cronbach’s alpha >0.70 [34,35,44,52-54], but failed to
report the internal consistency for the total scale. However,
interpretation of internal consistency findings should always
consider that when a subscale has a large number of items,
Cronbach’s alpha can be artificially high [59,60]. Test-retest
validity was very rarely considered during the development
of PROMs assessing patient-centred cancer care. Although
four of the five measures that examined test-retest
reliability administered a second survey within 2-14 days
[33,35,38,53], none of the measures demonstrated accept-
able agreement between scores for the total scale, subscales
and items across the two administrations [18,19]. However
possible explanations for the lack of adequate test-retest
reliability among PROMs assessing patient-centred cancer
care may include that: 1) patients’ experiences of care,particularly for those receiving active treatment, actually
changed between the initial and second administration of
the measure; and 2) completing the initial measure altered
patients’ expectations of patient-centred care and as a result
patients rated their care differently during the second ad-
ministration of the measure. Nonetheless, future research
that develops PROMs of patient-centred cancer care, or
validates existing measures should examine test-retest reli-
ability, with the aim of achieving high item-to-item agree-
ment. Item-to-item agreement is necessary [21], as high
agreement between overall subscale scores can be obtained
even when corresponding items within the subscale are an-
swered differently across the two administrations.
In terms of the validity of the PROMs developed to
assess patient-centred care, most of the measures met
the criteria considered adequate for face/content validity
(15 of 21 measures) and construct validity (18 of 21
measures). Factor analysis was the most common strat-
egy adopted to measure construct validity (16 measures),
however, few studies indicated whether eigenvalues >1
[24] were achieved [33,41,44,47,48,50,53]. Eigenvalues
are used to determine the number of subscales within
the measure by applying the eigenvalues >1 rule which
produces psychometrically reliable and psychologically
meaningful results [24]. Thus improvements to reporting
whether eigenvalues were >1 appears necessary for
PROMs that examine patient-centred cancer care.
The context in which these PROMs assessed patient-
centred cancer care should be considered. Most measures
were developed with cancer patients recruited from hospi-
tals or treatment centres [33,34,38-44,46-50,53-55]. Only
one measure was developed with patients recruited via a
population-based cancer registry [32], despite benefits of
such recruitment including the ability to sample a represen-
tative group of patients at different stages of the disease
and with varied experiences of cancer care [61]. Although
measuring the quality of patient-centred cancer care during
initial treatment and hospital visits is crucial, undertaking
such assessments with cancer survivors who no longer visit
the hospital regularly is also important. For instance,
women diagnosed with breast cancer have reported that
the quality and duration of their follow-up consultations
with clinicians had declined compared to the quality and
duration of their initial treatment experiences [62].
The limitations of this review include that studies
available in a non-English language peer-reviewed jour-
nal and the grey literature were excluded which could
have led to some bias in the findings. Furthermore, the
survey developers’ reasons for constructing the PROM
should be considered. It is possible that the PROM’s
objective may have been to focus on specific features of
patient-centred care rather than to include items that cov-
ered the IOM’s six dimensions of patient-centred care. This
may explain why most PROMs did not adequately address
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ally, insufficient or unavailable reporting of the 21 PROMs’
psychometric properties may have influenced the ratings
regarding the adequacy of the measure’s psychometric
properties. We did not contact the authors of each PROM
to enquire if additional unpublished psychometric informa-
tion was available for that measure.
Conclusions
Quality improvements to the health care system can be
guided by PROMs assessing the quality of patient-centred
cancer care. The Indicators (Non-small Cell Lung Cancer)
measure [40] was the only identified PROM that included
questions relating to the six IOM endorsed dimensions of
patient-centred care [1], however psychometric inadequa-
cies and/or incomplete reporting indicates that further psy-
chometric testing of this measure is required. Using more
than one measure or further developing existing measures
to include all six patient-centred care dimensions could im-
prove the assessment and the delivery of patient-centred
care. Additionally, given the lack of psychometrically rigor-
ous PROMs developed to assess patient-centred cancer
care that capture the six IOM dimensions, the construction
of new comprehensive measures whose psychometric prop-
erties are adequate may also be warranted.
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